| Sleep Apnea |
1 |
1 |
| Lipids Management |
0 |
0.65 |
| Sleep |
0 |
0.58 |
| Triglycerides |
0 |
0.58 |
| Obstructive Sleep Apnea |
0 |
0.99 |
| Metabolic Syndrome |
0 |
0.42 |
| Metabolism |
0 |
0.4 |
| Sleep Disorders |
0 |
0.4 |
| Cardiovascular Risk Management |
0 |
0.37 |
| Obesity |
0 |
0.26 |
| Hypertension |
0 |
0.22 |
| High Density Lipoprotein (HDL) cholesterol |
0 |
0.18 |
| Dyslipidemia |
0 |
0.17 |
| Lipoproteins |
0 |
0.17 |
| Cardiometabolic Risk Factors |
0 |
0.14 |
| Cardiovascular disease |
0 |
0.12 |
| Hypoxia |
0 |
0.12 |
| Insulin Resistance |
0 |
0.12 |
| Oxidative Stress |
0 |
0.12 |
| Stress |
0 |
0.12 |
| Rapid Eye Movement |
0 |
0.08 |
| Type 2 Diabetes Mellitus |
0 |
0.07 |
| Airway |
0 |
0.06 |
| Atherosclerosis |
0 |
0.06 |
| Blood |
0 |
0.06 |
| Body Mass Index |
0 |
0.06 |
| Grant |
0 |
0.06 |
| Hospital |
0 |
0.06 |
| Hypertriglyceridemia |
0 |
0.06 |
| Orbit |
0 |
0.06 |
| Polysomnography |
0 |
0.06 |
| Tissue |
0 |
0.06 |